Cargando…
Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents
Tuberculosis is one of the leading cause of death in the world, mainly due to the increasing number of multidrug‐resistant TB (MDR‐TB) and extensively drug‐resistant TB (XDR‐TB) strains. Factors such as the HIV pandemic contribute further. Also, the ineffectiveness of the chemotherapy in current use...
Autor principal: | Bvumbi, Mpelegeng Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756396/ https://www.ncbi.nlm.nih.gov/pubmed/32844566 http://dx.doi.org/10.1002/cmdc.202000580 |
Ejemplares similares
-
Riminophenazine Derivatives as Potential Antituberculosis Agents: Synthesis, Biological, and Electrochemical Evaluations
por: Bvumbi, Mpelegeng Victoria, et al.
Publicado: (2021) -
Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents
por: Zhang, Dongfeng, et al.
Publicado: (2014) -
Mycobacterium tuberculosis resistance to antituberculosis drugs in
Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014) -
In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
por: Ying, Ruoyan, et al.
Publicado: (2021) -
Regulatory roles of extracellular vesicles in immune responses against Mycobacterium tuberculosis infection
por: Yan, Zhi, et al.
Publicado: (2021)